Provided are: a light-emitting layer for a perovskite light-emitting device; a method for manufacturing the same; and a perovskite light-emitting device using the same. The method of the present invention for manufacturing a light-emitting layer for a halide perovskite light-emitting device comprises a step of forming a first nanoparticle thin film by coating, on a member for coating a light-emitting layer, a solution comprising halide perovskite nanoparticles including a perovskite nanocrystal structure. Thereby, a nanoparticle light emitter has therein a halide perovskite having a crystal structure in which FCC and BCC are combined; and can show high color purity. In addition, it is possible to improve the luminescence efficiency and luminance of a device by making perovskite as nanoparticles and then introducing the same into a light-emitting layer.

Devices, compositions, and methods are described which provide a tubular nanostructure or a composite tubular nanostructure targeted to a lipid bilayer membrane. The tubular nanostructure includes a hydrophobic surface region flanked by two hydrophilic surface regions. The tubular nanostructure is configured to interact with a lipid bilayer membrane and form a pore in the lipid bilayer membrane. The tubular nanostructure may be targeted by including at least one ligand configured to bind to one or more cognates on the lipid bilayer membrane of a target cell.

Stabilized luminescent nanoparticles for light emitting diode applications comprise perovskite nanocrystals encapsulated by an oxide coating, where the oxide coating includes ligand remnants comprising one or more elements selected from the group consisting of: nitrogen, carbon, phosphorus, and sulfur. A method of making the stabilized luminescent nanoparticles comprises dispersing perovskite nanocrystals and crosslinking ligands in a non-polar solvent to form a first mixture. Each of the crosslinking ligands comprises a head end and a tail end; the head ends attach to the perovskite nanocrystals and the tail ends remain unattached and available for crosslinking. An oxide precursor comprising crosslinking functional groups is added to the first mixture, and the crosslinking functional groups attach to the tail ends of the crosslinking ligands. Thus, an oxide coating is formed on the perovskite nanocrystals.

Devices, compositions, and methods are described which provide a tubular nanostructure or a composite tubular nanostructure targeted to a lipid bilayer membrane. The tubular nanostructure includes a hydrophobic surface region flanked by two hydrophilic surface regions. The tubular nanostructure is configured to interact with a lipid bilayer membrane and form a pore in the lipid bilayer membrane. The tubular nanostructure may be targeted by including at least one ligand configured to bind to one or more cognates on the lipid bilayer membrane of a target cell.

This application discloses a method for developing a conductive nano-gap. The first step can comprise depositing a brittle material on a substrate. Next, a conductive graphene layer can be deposited at the surface of the brittle material. Lastly, a crack can be propagated through the brittle material and the graphene using a force, the crack a nano-gap.

An epitaxial structure and a method for making the same are provided. The epitaxial structure includes a substrate, an epitaxial layer and a carbon nanotube layer. The epitaxial layer is located on the substrate. The carbon nanotube layer is located in the epitaxial layer. The method includes following. A substrate having an epitaxial growth surface is provided. A carbon nanotube layer is suspended above the epitaxial growth surface. An epitaxial layer is epitaxially grown from the epitaxial growth surface to enclose the carbon nanotube layer therein. The epitaxial layer is a substantially homogenous material from the substrate.

The present invention provides compositions comprising a poorly water soluble pharmaceutical agent, a carrier protein, and an antimicrobial agent, wherein significant microbial growth is inhibited in the composition. The amount of the antimicrobial agent in the composition may be below the level that induces a toxicological effect or at a level where a potential side effect can be controlled or tolerated. Also provided are compositions comprising a poorly water soluble pharmaceutical agent, a carrier protein, a sugar, and optionally an antimicrobial agent. Methods of using the compositions are also provided.

Provided are: a light-emitting layer for a perovskite light-emitting device; a method for manufacturing the same; and a perovskite light-emitting device using the same. The method of the present invention for manufacturing a light-emitting layer for an organic and inorganic hybrid perovskite light-emitting device comprises a step of forming a first nanoparticle thin film by coating, on a member for coating a light-emitting layer, a solution comprising organic and inorganic perovskite nanoparticles including an organic and inorganic perovskite nanocrystalline structure. Thereby, a nanoparticle light emitter has therein an organic and inorganic hybrid perovskite having a crystalline structure in which FCC and BCC are combined; forms a lamella structure in which an organic plane and an inorganic plane are alternatively stacked; and can show high color purity since excitons are confined to the inorganic plane. In addition, it is possible to improve the luminescence efficiency and luminance of a device by making perovskite as nanoparticles and then introducing the same into a light-emitting layer.

Stabilized luminescent nanoparticles for light emitting diode applications comprise perovskite nanocrystals encapsulated by an oxide coating, where the oxide coating includes ligand remnants comprising one or more elements selected from the group consisting of: nitrogen, carbon, phosphorus, and sulfur. A method of making the stabilized luminescent nanoparticles comprises dispersing perovskite nanocrystals and crosslinking ligands in a non-polar solvent to form a first mixture. Each of the crosslinking ligands comprises a head end and a tail end; the head ends attach to the perovskite nanocrystals and the tail ends remain unattached and available for crosslinking. An oxide precursor comprising crosslinking functional groups is added to the first mixture, and the crosslinking functional groups attach to the tail ends of the crosslinking ligands. Thus, an oxide coating is formed on the perovskite nanocrystals.

Disclosed are a light-emitting layer for a perovskite light-emitting device, a method for manufacturing the same, and a perovskite light-emitting device using the same. The method of manufacturing the light-emitting layer comprises a step of forming a first nanoparticle thin film by coating, on a substrate for coating a light-emitting layer, a solution comprising organic and inorganic perovskite nanoparticles. Thereby, a nanoparticle light emitter has therein an organic and inorganic hybrid perovskite having a crystalline structure in which FCC and BCC are combined, and has a lamella structure in which an organic plane and an inorganic plane are alternatively stacked. Also, high color purity is realized because excitons are confined to the inorganic plane.